Next Article in Journal
Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation
Next Article in Special Issue
Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm
Previous Article in Journal
Conformational and Immunogenicity Studies of the Shigella flexneri Serogroup 6 O-Antigen: The Effect of O-Acetylation
Previous Article in Special Issue
Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19
 
 
Review

Article Versions Notes

Vaccines 2021, 9(5), 433; https://doi.org/10.3390/vaccines9050433
Action Date Notes Link
article pdf uploaded. 27 April 2021 13:18 CEST Version of Record https://www.mdpi.com/2076-393X/9/5/433/pdf-vor
article xml file uploaded 28 April 2021 11:32 CEST Original file -
article xml uploaded. 28 April 2021 11:32 CEST Update https://www.mdpi.com/2076-393X/9/5/433/xml
article pdf uploaded. 28 April 2021 11:32 CEST Updated version of record https://www.mdpi.com/2076-393X/9/5/433/pdf
article html file updated 28 April 2021 11:34 CEST Original file -
article html file updated 26 July 2022 17:05 CEST Update https://www.mdpi.com/2076-393X/9/5/433/html
Back to TopTop